Clinical Trials on Fructose Metabolism Disorder

Total 161667 results

Merck Sharp & Dohme LLC

Withdrawn

Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)

Dyslipidemia
Maastricht University Medical Center
DSM Nutritional Products, Inc.

Completed

Resveratrol and Serum Apo A-I

Dyslipidemia

Netherlands
AstraZeneca
Fundació Institut Català de Farmacologia

Withdrawn

Observational Study To Evaluate Statins Patterns Of Use In Spain

Dyslipidemia

Spain
Catabasis Pharmaceuticals

Completed

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

Dyslipidemia

United States
Akros Pharma Inc.

Completed

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States
University of Virginia
University of Texas; U.S. Army Medical Research and Development Command

Unknown

Pilot Study of Intensive Care Unit Continuous Glucose Monitoring

Hyperglycemia | Hypoglycemia

United States
UCSF Benioff Children's Hospital Oakland
Dairy Management Inc.

Completed

Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL)

Dyslipidemia

United States
Bristol-Myers Squibb

Completed

Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia

Dyslipidemia

United States, Canada
MaiHealth Inc

Unknown

Longitudinal Study of Multi-Analyte Profile for Dyslipidemia

Dyslipidemia

United States
Indonesia University

Completed

Effect of Nigella Sativa on Lipid Profiles in Elderly

Dyslipidemia

Indonesia
AstraZeneca

Completed

Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

Dyslipidemia

Mexico
Enzymotec

Completed

Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels

Dyslipidemia

Israel
AstraZeneca

Completed

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESENDO)

Dyslipidemia

Korea, Republic of
Sheba Medical Center

Unknown

Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences

Iron Overload

Israel
Hospital de Clinicas de Porto Alegre

Completed

Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period

Dyslipidemia

Brazil
CHU de Quebec-Universite Laval
AstraZeneca

Completed

Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia

Dyslipidemia

Canada
Stanford University

Not yet recruiting

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness

Obesity | Metabolic Syndrome | Bipolar Disorder | Bipolar and Related Disorders | Bipolar Depression | Weight Gain | Bipolar I Disorder | Ketogenic Dieting | Bipolar Disorder I | Bipolar II Disorder | Psychotropic Agents Causing Adverse Effects in Therapeutic Use | Brain Metabolic Disorder | Bipolar Disorder, Type... and other conditions

United States
Haugaard, Steen Bendix, M.D., DMSc
Hölmich, Per, M.D.

Unknown

Metabolic Complications Following Knee Injury in Young and Middle Aged Patients (OrthoMetKnee)

Glucose Metabolism Disorders | Sedentary Lifestyle | Lipid Metabolism Disorders

Denmark
Novo Nordisk A/S

Completed

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Terminated

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

Obesity | Metabolism and Nutrition Disorder

United States
Atlas Biomed

Withdrawn

Dietary Fibers Effect on the Gut Microbiota Composition

Inflammation | Metabolic Syndrome | Dyslipidemias | Cardiovascular Risk Factor | Microbiome

Russian Federation
University of California, San Francisco
University of California, Berkeley; Agency for Healthcare Research and Quality...

Completed

Diabetes and Depression Text Messaging Intervention (DIAMANTE)

Depression | Diabetes | Physical Activity

United States
Swiss Federal Institute of Technology
Instituto de Investigação em Imunologia

Completed

Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement

Iron Metabolism Disorders | Iron Overload | Polyphenols

Portugal, Switzerland
Wake Forest University Health Sciences

Completed

EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) (EMERALD)

Lipid Disorder

United States
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Enrolling by invitation

The BEET Diabetes Feasibility Trial

Disordered Eating Behaviors

United States
Horizon Therapeutics, LLC

Terminated

Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs) (THRIVE)

Urea Cycle Disorder

United States
Oregon State University

Completed

Mitochondrial Remodeling After Exercise

Sedentary Lifestyle | Insulin Resistance | Overweight and Obesity | Metabolic Disease | Mitochondrial Metabolism

United States
University of Manitoba
Co-Investigator - Dr. Cheryl Rockman-Greenberg

Completed

Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial (Glycosade GSD)

Hypoglycemia | Glycogen Storage Disorder Type 1 | Cornstarch | Glycosade

Canada
Vital Signs Solutions Ltd

Recruiting

PocDoc Lipids Out-of-Surgery Study

Dyslipidemias

United Kingdom
Assiut University

Not yet recruiting

Assessment of Epicardial Fat Thickness in Children With Familial Dyslipidemia

Dyslipidemia
Daewoong Pharmaceutical Co. LTD.

Recruiting

A Study to Evaluate the Efficacy and Safety of CREZET Tablet

Dyslipidemias

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506. (Atorf-YOOrct)

Dyslipidemias

Korea, Republic of
University of Pisa
IRCCS Burlo Garofolo; University of Genova

Recruiting

Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT

Iron Overload

Italy
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

Dyslipidemias

Korea, Republic of
University of Leipzig
Charite University, Berlin, Germany; University of Jena; University Hospital...

Active, not recruiting

Statin-Intolerance Registry (SIR)

Dyslipidemias

Germany
Kowa Research Institute, Inc.

Completed

Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

Dyslipidemia

United States
AstraZeneca

Completed

A Study of AZD8233 in Participants With Dyslipidemia. (HAYATE)

Dyslipidemia

Japan
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia

Dyslipidemia

Korea, Republic of
University of Utah

Terminated

The Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin Levels

Iron Overload

United States
Organon and Co

Withdrawn

A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406) (VYCTORY)

Dyslipidemia
Kowa Company, Ltd.

Completed

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Sang Yeoup Lee

Completed

Ulmus Macrocarpa Hance Extract and Lipid Profile

Dyslipidemias

Korea, Republic of
Eli Lilly and Company

Completed

A Study of LY3475766 in Healthy Participants

Dyslipidemias

United States
Kowa Company, Ltd.

Completed

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

Dyslipidemias

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study (AT GOAL)

Dyslipidemias

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

Dyslipidemias

Belgium
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand

Dyslipidemias

Thailand
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol (LA ATGOAL)

Dyslipidemias

Brazil, Colombia, Panama, Mexico, Guatemala, Chile, Ecuador, Venezuela

Clinical Trials on Fructose Metabolism Disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations